SCHEMBL29059911

SCHEMBL29059911

COc1cc(N2CCC(N3CCN(CC(=O)O)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2N[S+](C)[O-])n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 10/20 0.66
▸ INSR P06213 11/20 0.65
▸ IGF1R P08069 11/20 0.65
▸ ALK Q9UM73 11/20 0.65
▸ CHEK1 O14757 1/20 0.61
▸ AURKA O14965 1/20 0.61
▸ NUAK1 O60285 1/20 0.61
▸ JAK2 O60674 1/20 0.61
▸ STK10 O94804 1/20 0.61
▸ PRKD3 O94806 1/20 0.61
▸ SLC34A2 O95436 1/20 0.61
▸ CHEK2 O96017 1/20 0.61
▸ ABL1 P00519 1/20 0.61
▸ CD74 P04233 1/20 0.61
▸ ERBB2 P04626 1/20 0.61
▸ LCK P06239 1/20 0.61
▸ FYN P06241 1/20 0.61
▸ FES P07332 1/20 0.61
▸ CSF1R P07333 1/20 0.61
▸ YES1 P07947 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29059662 0.93 EGFR (0.67) EGFRINSRIGF1RALKCHEK1
Hydrochloric Acid SCHEMBL29059831 0.91 ALK (0.63) EGFRINSRIGF1RALK
Hydrochloric Acid SCHEMBL29059862 0.89 ALK (0.61) EGFRINSRIGF1RALK
SCHEMBL23044816 0.87 ALK (0.81) EGFRINSRIGF1RALKCHEK1
SCHEMBL29059669 0.86 EGFR (0.62) EGFRINSRIGF1RALK
SCHEMBL29059681 0.86 EGFR (0.58) EGFRINSRIGF1RALKCHEK1
SCHEMBL29059673 0.86 EGFR (0.68) EGFRINSRIGF1RALKCHEK1
SCHEMBL29059883 0.85 ALK (0.62) EGFRINSRIGF1RALK
SCHEMBL26498063 0.85 EGFR (0.81) EGFRINSRIGF1RALKCHEK1
SCHEMBL29059829 0.84 ALK (0.60) EGFRINSRIGF1RALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116490184-A Compounds for inhibiting EGFR mutant cancers and pharmaceutical uses thereof J2H生物科技有限公司 2023-07-25 — — CN disclosed
Send feedback